CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-α

Oncogene

Volumn 32, Issue 41, 2013, Pages 4883-4891

  Li, S ^a   Wang, M ^a   Ao, X ^a   Chang, A K ^a   Yang, C ^a   Zhao, F ^a   Bi, H ^a   Liu, Y ^a   Xiao, L ^a   Wu, H ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

CLOCK; ERa; estrogen; sumoylation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; LYSINE; PROTEIN SENP1; SUMO PROTEIN; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CLOCK PROTEINS; COS CELLS; ENDOPEPTIDASES; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; MCF-7 CELLS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84885598880     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.518     Document Type: Article

References (48)

1. Sternlicht MD. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res 2006; 8: 201.
2. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354: 270-282.
3. Pearce ST, Jordan VC. The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Oncol Hematol 2004; 50: 3-22. (Pubitemid 38501614)
4. Wu H, Chen Y, Liang J, Shi B, Wu G, Zhang Y et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 2005; 438: 981-987. (Pubitemid 43093965)
5. Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM et al. Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 1985; 82: 7889-7893. (Pubitemid 16179869)
6. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925-5930. (Pubitemid 26190778)
7. Stade K, Vogel F, Schwienhorst I, Meusser B, Volkwein C, Nentwig B et al. A lack of SUMO conjugation affects cNLS-dependent nuclear protein import in yeast. J Biol Chem 2002; 277: 49554-49561. (Pubitemid 36014394)
8. Mill P, Mo R, Fu H, Grachtchouk M, Kim PC, Dlugosz AA et al. Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. Genes Dev 2003; 17: 282-294. (Pubitemid 36105899)
9. Dutertre M, Smith CL. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol Endocrinol 2003; 17: 1296-1314. (Pubitemid 36819952)
10. Kotaja N, Karvonen U, Janne OA, Palvimo JJ. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem 2002; 277: 30283-30288.
11. Wu H, Sun L, Zhang Y, Chen Y, Shi B, Li R et al. Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J Biol Chem 2006; 281: 21848-21856. (Pubitemid 44181888)
12. Chauchereau A, Amazit L, Quesne M, Guiochon-Mantel A, Milgrom E. Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J Biol Chem 2003; 278: 12335-12343. (Pubitemid 36800217)
13. Li S, Yang C, Hong Y, Bi H, Zhao F, Liu Y et al. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 Ligase PIAS1. Biol Cell 2012; 104: 287-296.
14. Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP. The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 2007; 26: 7916-7920. (Pubitemid 350262755)
15. Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett 2009; 281: 1-7.
16. Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y et al. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res 2010; 70: 1459-1468.
17. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 2007; 9: 797-800. (Pubitemid 47623419)
18. Kuo SJ, Chen ST, Yeh KT, Hou MF, Chang YS, Hsu NC et al. Disturbance of circadian gene expression in breast cancer. Virchows Arch 2009; 454: 467-474.
19. Lee CC. Tumor suppression by the mammalian Period genes. Cancer Causes Control 2006; 17: 525-530.
20. Dunlap JC. Molecular bases for circadian clocks. Cell 1999; 96: 271-290. (Pubitemid 29059356)
21. Lowrey PL, Takahashi JS. Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu Rev Genet 2000; 34: 533-562. (Pubitemid 32065932)
22. Young MW, Kay SA. Time zones: a comparative genetics of circadian clocks. Nat Rev Genet 2001; 2: 702-715. (Pubitemid 33674792)
23. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006; 125: 497-508.
24. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999; 98: 193-205. (Pubitemid 29344907)
25. van der Horst GT, Muijtjens M, Kobayashi K, Takano R, Kanno S, Takao M et al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 1999; 398: 627-630. (Pubitemid 29183691)
26. Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci USA 1999; 96: 12114-12119. (Pubitemid 29502867)
27. Shim HS, Kim H, Lee J, Son GH, Cho S, Oh TH et al. Rapid activation of CLOCK by Ca2 +-dependent protein kinase C mediates resetting of the mammalian circa-dian clock. EMBO Rep 2007; 8: 366-371. (Pubitemid 46511037)
28. Spengler ML, Kuropatwinski KK, Schumer M, Antoch MP. A serine cluster mediates BMAL1-dependent CLOCK phosphorylation and degradation. Cell Cycle 2009; 8: 4138-4146.
29. Seeler JS, Dejean A. Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 2003; 4: 690-699. (Pubitemid 37082184)
30. Cardone L, Hirayama J, Giordano F, Tamaru T, Palvimo JJ, Sassone-Corsi P. Circadian clock control by SUMOylation of BMAL1. Science 2005; 309: 1390-1394. (Pubitemid 41209369)
31. Hong Y, Xing X, Li S, Bi H, Yang C, Zhao F et al. SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS ONE 2011; 6: e23046.
32. Bailey D, O'Hare P. Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. J Gen Virol 2002; 83(Pt 12): 2951-2964. (Pubitemid 36054340)
33. Gong L, Millas S, Maul GG, Yeh ET. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem 2000; 275: 3355-3359. (Pubitemid 30083039)
34. Hang J, Dasso M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J Biol Chem 2002; 277: 19961-19966. (Pubitemid 34967518)
35. Gong L, Yeh ET. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem 2006; 281: 15869-15877. (Pubitemid 43848478)
36. Yang C, Trent S, Ionescu-Tiba V, Lan L, Shioda T, Sgroi D et al. Identification of cyclin D1-and estrogen-regulated genes contributing to breast carcinogenesis and progression. Cancer Res 2006; 66: 11649-11658. (Pubitemid 46094176)
37. Tanimura N, Kusunose N, Matsunaga N, Koyanagi S, Ohdo S. Aryl hydrocarbon receptor-mediated Cyp1a1 expression is modulated in a CLOCK-dependent circadian manner. Toxicology 2011; 290: 204-208.
38. Cai W, Rambaud J, Teboul M, Masse I, Benoit G, Gustafsson JA et al. Expression levels of estrogen receptor beta are modulated by components of the molecular clock. Mol Cell Biol 2008; 28: 784-793.
39. Al-Dhaheri M, Wu J, Skliris GP, Li J, Higashimato K, Wang Y et al. CARM1 is an important determinant of ERalpha-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Cancer Res 2011; 71: 2118-2128.
40. Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D et al. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains. J Biol Chem 2000; 275: 15645-15651. (Pubitemid 30366859)
41. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E et al. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 1999; 13: 1672-1685. (Pubitemid 30645272)
42. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev 2005; 15: 536-541. (Pubitemid 41262410)
43. Johnson ES. Protein modification by SUMO. Annu Rev Biochem 2004; 73: 355-382. (Pubitemid 39050373)
44. Osborne CK. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 1998; 51: 227-238. (Pubitemid 29054556)
45. Sheikh MS, Garcia M, Pujol P, Fontana JA, Rochefort H. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis 1994; 14: 329-336.
46. Antoch MP, Gorbacheva VY, Vykhovanets O, Toshkov IA, Kondratov RV, Kondratova AA et al. Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle 2008; 7: 1197-1204. (Pubitemid 351749273)
47. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004; 304: 596-600. (Pubitemid 38541920)
48. Cascone I, Napione L, Maniero F, Serini G, Bussolino F. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol 2005; 170: 993-1004. (Pubitemid 41306298)